Participating investors have contributed over €200 billion in total investments in the past.
Tech Tour has just announced the selected companies for the Tech Tour Growth Health 2024 Programme. Forty-one growth companies working in the Digital Health and MedTech sectors were chosen out of a large pool of applicants by a Selection Panel of 55 active investors, using a collaborative scouting and review methodology. (See the companies below.)
The investment programme is presided over by serial entrepreneurs Fredrik Debong from Onetwenty.ai, with Tanja Dowe, Managing Director of Angelini Ventures, serving as Vice President of the Selection Panel.
Tanja states, “I love to work with entrepreneurs and I’m passionate about solving our healthcare problems through new solutions and technologies. Tech Tour Growth Health offers a unique opportunity to see the full landscape of what startups are working on in Europe today.”
Fredrik adds, “In my role, I wish to give the event a bit more depth regarding current topics, to stand out in comparison with other events we visit. I believe we achieve this with a focus on regulations and AI, as well as making the format of our sessions more personal.”
Key data of participating investors and selected companies:
Investor commitment: The participating investors collectively have made 3,101 investments in the past, contributing to €200.3 billion. These investors comprise 69% investment funds and 31% corporates. The significant investment history underscores their dedication to advancing the health tech industry.
Total funding achieved: The selected companies historically already have raised €592.5 million. This impressive funding achievement highlights their potential and the confidence investors have in their innovations.
Top countries by selected companies: The selection spans across Europe, with Switzerland leading with 14 companies. Germany follows with 6 companies, while Belgium, Finland and Israel each have 3 companies represented.
Most represented subsectors: The companies are primarily distributed across key subsectors, with medical devices accounting for 45%, biotechnology representing 29%, and health platforms comprising 23%.
For more insights see the Infogram below.
The selected companies will present their groundbreaking technologies at the Tech Tour Growth Health 2024 event on 10 and 11 September 2024 in Lausanne, Switzerland.
The event is supported by our partners: Canton de Vaud, Innovaud, Medtronic, Tüv Süd, BioAlps, and Biopôle.
Don't miss the opportunity to be at the cutting edge of innovation and connect with the future leaders of health tech. Secure your spot HERE and sign up for our monthly newsletter below.
